Home›Trial›NCT06910306
🔬NCT06910306NARECRUITING

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

Study Summary

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for the treatment of recurrent Glioblastoma

Conditions
Recurrent GlioblastomaRecurrent Gliomas
Interventions / Drugs
Device :DaRT seeds
View on ClinicalTrials.gov ↗
Sponsor
DRTS
Alpha Tau Medical Ltd.
Biotech / Pharma
F17/100
Study Details
Enrollment10 participants
Primary Completion—
Lead SponsorAlpha Tau Medical LTD.
Data Retrieved2026-06-17 02:56:49.846186+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.